Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

725 ARTÍCULOS , VIENDO DEL 301 AL 315

The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations

York MK, Farace E, Pollak L, Floden D, Lin G, Wyman-Chick K, Bobholz J, Palmese CA, Racine C, Tran B, Turner TH, Jimenez-Shahed J; of the Parkinson Study Group Functional Neurosurgical Working Group.

Parkinsonism Relat Disord. 2021 May;86:135-138. doi: 10.1016/j.parkreldis.2021.04.029. Epub 2021 May 14.

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study

Vijiaratnam N, Girges C, Auld G, Chau M, Maclagan K, King A, Skene S, Chowdhury K, Hibbert S, Morris H, Limousin P, Athauda D, Carroll CB, Hu MT, Silverdale M, Duncan GW, Chaudhuri R, Lo C, Del Din S, Yarnall AJ, Rochester L, Gibson R, Dickson J, Hunter R, Libri V, Foltynie T.

BMJ Open. 2021 May 28;11(5):e047993. doi: 10.1136/bmjopen-2020-047993.

Tremor and Parkinsonism in Chromosomopathies - A Systematic Review

Carvalho V, Ferreira JJ, Correia Guedes L.

Mov Disord. 2021 Sep;36(9):2017-2025. doi: 10.1002/mds.28663. Epub 2021 May 31.

α-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's Disease

Isonaka R, Goldstein DS, Zhu W, Yoon E, Ehrlich D, Schindler AB, Kokkinis AD, Sabir MS, Scholz SW, Bandres-Ciga S, Blauwendraat C, Gonzalez-Alegre P, Lopez G, Sidransky E, Narendra DP.

Mov Disord. 2021 Oct;36(10):2346-2357. doi: 10.1002/mds.28667. Epub 2021 Jun 2.

Covid-19 Infection and Parkinsonism: Is There a Link?

Bouali-Benazzouz R, Benazzouz A.

Mov Disord. 2021 Aug;36(8):1737-1743. doi: 10.1002/mds.28680. Epub 2021 Jun 8.

Expanding sexual and gender minority research in movement disorders: More than awareness and acceptance

Lin CR, Rosendale N, Deeb W.

Parkinsonism Relat Disord. 2021 Jun;87:162-165. doi: 10.1016/j.parkreldis.2021.05.019. Epub 2021 May 24.

Peripheral Immune Profile and Neutrophil-to-Lymphocyte Ratio in Parkinson's Disease

Muñoz-Delgado L, Macías-García D, Jesús S, Martín-Rodríguez JF, Labrador-Espinosa MÁ, Jiménez-Jaraba MV, Adarmes-Gómez A, Carrillo F, Mir P.

Mov Disord. 2021 Oct;36(10):2426-2430. doi: 10.1002/mds.28685. Epub 2021 Jun 8.

[The questions of the treatment of Parkinson's disease]

Nagy F.

Ideggyogy Sz. 2021 May 30;74(5-6):151-155. doi: 10.18071/isz.74.0151.

Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12-Week, Randomized, Controlled Study

Müller-Vahl KR, Fremer C, Beals C, Ivkovic J, Loft H, Schindler C.

Mov Disord. 2021 Oct;36(10):2413-2418. doi: 10.1002/mds.28681. Epub 2021 Jun 12.

Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease

Fiorenzato E, Antonini A, Bisiacchi P, Weis L, Biundo R.

Mov Disord. 2021 Oct;36(10):2303-2313. doi: 10.1002/mds.28682. Epub 2021 Jun 14.

The Gastrointestinal Dysfunction Scale for Parkinson's Disease

Camacho M, Greenland JC, Williams-Gray CH.

Mov Disord. 2021 Oct;36(10):2358-2366. doi: 10.1002/mds.28675. Epub 2021 Jun 16.

A Randomized, Placebo-Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome

Garcia-Borreguero D, Garcia-Malo C, Granizo JJ, Ferré S.

Mov Disord. 2021 Oct;36(10):2387-2392. doi: 10.1002/mds.28668. Epub 2021 Jun 17.

The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson's Disease

Ren H, Zhai W, Lu X, Wang G.

Front Aging Neurosci. 2021 Jun 3;13:691881. doi: 10.3389/fnagi.2021.691881. eCollection 2021.

A case of drug-induced parkinsonism and tardive akathisia with e1143g polymerase γ mutation-innocent bystander or a culprit?

Idiculla PS, Hussain ST, Siddiqui JH.

J Clin Transl Res. 2021 May 14;7(3):297-301. eCollection 2021 Jun 26.

Short-term effect and its retention of LSVT® BIG on QOL improvement: 1-year follow-up in a patient with Parkinson's disease

Hirakawa Y, Koyama S, Takeda K, Iwai M, Motoya I, Sakurai H, Kanada Y, Kawamura N, Kawamura M, Tanabe S.

NeuroRehabilitation. 2021;49(3):501-509. doi: 10.3233/NRE-210129.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias